Global Medication-Assisted Treatment (MAT) Market is Driven by Increase in MAT Counselling and Acceptance of MAT as A Treatment Modality

Medication-Assisted Treatment (MAT) Market is estimated to grow at a rate of 3.20% for 2021 to 2028 with factors such as, limited number of treatment options, heavy regulatory regulations, inefficient reimbursement policies, restraining the market growth in the above mentioned forecasted period.

Medication-assisted treatment (MAT) market has shown an exceptional penetration in developed economies in North America due to increase case of opioid intake and counselling and increasing awareness towards opioid over-use in this region.

Medication-Assisted Treatment (MAT) Market Scenario

According to Data Bridge Market Research medication-assisted treatment (MAT) market is witnessing a significant growth in developed economies during the forecast period of 2021-2028 due to factors such as, rise in the number of the population seeking MAT and increase in counselling with healthcare professionals will additionally heighten numerous, driving the market swiftly. Moreover, rise in the research and development activities in the market will further create new opportunities for medication-assisted treatment (MAT) market in the forecast period of 2021-2028.

Now the question is which are the other regions medication-assisted treatment (MAT) market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific medication-assisted treatment (MAT) market to be their next revenue pockets for 2020. The Data bridge market research new reports highlight the major growth factors and opportunities in the medication-assisted treatment (MAT) market.

For more analysis on the medication-assisted treatment (MAT) market request for a briefing with our analysts.

Scope of the Medication-Assisted Treatment (MAT) Market Scenario

Medication-assisted treatment (MAT) market is segmented on the basis of countries U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, in Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

  • All country based analysis of medication-assisted treatment (MAT) market is further analyzed based on maximum granularity into further segmentation. On the basis of gender type, the medication-assisted treatment (MAT) market is segmented into male and female. On the basis of drug type, the medication-assisted treatment (MAT) market is segmented into branded and generics. On the basis of route of administration, the medication-assisted treatment (MAT) market is segmented into oral, parenteral, nasal spray and others. On the basis of end user, the medication-assisted treatment (MAT) market is segmented into hospitals, rehabilitation clinics, speciality clinics and others. On the basis of distribution channel, the medication-assisted treatment (MAT) market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
  • Medication-assisted treatment (MAT) is the type of treatment that use medications in combination with counseling and behavioral therapies, which is effective in the treatment of opioid use disorders (OUD) and can help some people to sustain recovery.

To know more about the study

Key Pointers Covered in Medication-Assisted Treatment (MAT) Market and Forecast to 2028

  • Market Size
  •  Market New Sales Volumes
  •  Market Replacement Sales Volumes
  • Market Installed Base
  •  Market By Brands
  •  Market Procedure Volumes
  •  Market Product Price Analysis
  •  Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  •  Market Shares in Different Regions
  •  Recent Developments for Market Competitors
  •  Market Upcoming Applications
  •  Market Innovators Study

Key Market Competitors Covered in the report

  • Rosemont Pharmaceuticals Limited
  • Titan Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd
  • BioDelivery Sciences International, Inc.
  • Hikma Pharmaceuticals PLC
  • MediciNova, Inc
  • Orexo AB
  • Camurus AB
  • Indivior PLC
  • Mylan N.V.
  • Mallinckrodt
  • Eli Lilly and Company
  • Lipha S.A. (A Subsidiary of Merck KGaA)
  • Barr Pharmaceuticals, Inc
  • Omeros Corporation

Above are the key players covered in the report, to know about more and exhaustive list of medication-assisted treatment (MAT) market companies, contact us.

Research Methodology: Medication-Assisted Treatment (MAT) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@